• Теги
    • избранные теги
    • Компании125
      • Показать ещё
      Разное43
      • Показать ещё
      Страны / Регионы33
      • Показать ещё
      Показатели8
      Международные организации5
      Издания6
      Формат1
H Lundbeck
Выбор редакции
17 июля, 14:36

EU regulators charge Teva over pay-for-delay drug deal

EU antitrust regulators charged Israeli drugmaker Teva on Monday with doing an illegal deal with Cephalon to delay selling a cheaper generic version of the latter's sleep disorder drug, putting it at risk of a fine. The crackdown by the European Commission follows fines against scores of companies including Denmark's Lundbeck, U.S. giant Johnson & Johnson and France's Servier in recent years over similar deals. Teva, the world's biggest generic drugmaker, reached the deal with Cephalon as part of a settlement to end a lawsuit over alleged infringement of Cephalon's patents on the blockbuster drug.

11 июля, 22:50

3 Large Cap Pharma Stocks to Buy Now

The healthcare sector has dominated headlines this year thanks to promises from the GOP and the Trump administration related to repealing and replacing Obamacare. This uncertainty has not led to weak trading, and large cap pharma stocks have been among some of the biggest gainers this year. Check out these three large cap pharma stocks to buy now!

20 июня, 15:39

4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio

The Zacks-categorized Large Cap Pharmaceuticals industry is among the top 21% of the 256 Zacks-ranked industries -- here is a look at 4 top-ranked stocks from this sector.

12 июня, 20:44

3 Large Cap Pharma Stocks to Buy Now

Despite the uncertainty looming over the healthcare business, drug stocks have been doing well so far this year. Check out these three large cap pharma stocks to buy now!

18 мая, 15:45

4 Large-Cap Drug Stocks To Buy Post Q1 Earnings

Take a look at these four large-cap drug stocks including Merck (MRK) that look well-positioned post Q1 earnings.

10 мая, 22:36

3 Large Cap Drug Stocks to Buy Now

Our overall "Medical" sector is up about 7.78% year-to-date, which just edges out the gains of the S&P 500. Within this broad sector, one of the better performing industries has been what we call "Large Cap Pharmaceuticals."

03 мая, 01:40

What's in Store for Catalyst (CPRX) Stock in Q1 Earnings?

Catalyst Pharmaceuticals, Inc. (CPRX) is expected to report first-quarter 2017 results on May 11.

23 марта, 16:47

Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse

We issued an updated research report on Catalyst Pharmaceuticals, Inc. (CPRX) on Mar 22.

07 марта, 17:32

Catalyst Pharma (CPRX): What???s in Store in Q4 Earnings?

Catalyst Pharmaceuticals, Inc. (CPRX) is expected to report fourth-quarter 2016 results this month.

Выбор редакции
Выбор редакции
21 декабря 2016, 12:22

BRIEF-NNIT extends agreement with Lundbeck

* Estimated total value of agreement consisting of three contracts will amount in high double-digit million Danish crown range

25 ноября 2016, 15:00

Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?

Lilly's (LLY) failure has spooked investors who are now wondering whether other anti-amyloid treatments in development will face a similar fate.

08 ноября 2016, 17:30

Cirrus Logic, Skechers, Valeo SA ADR, H Lundbeck AS and Quanta Services highlighted as Zacks Bull and Bear of the Day

Cirrus Logic, Skechers, Valeo SA ADR, H Lundbeck AS and Quanta Services highlighted as Zacks Bull and Bear of the Day

07 ноября 2016, 18:38

12 Fun Facts About U.S. Presidential Elections: Global Week Ahead

Here are 12 facts I found most interesting (or funny!), and relevant to this U.S. election of 2016.

07 ноября 2016, 16:25

Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise?

Catalyst Pharmaceuticals, Inc. (CPRX) is scheduled to report third-quarter 2016 results on Nov 9, after market close.

Выбор редакции
02 ноября 2016, 10:10

Lundbeck climbs 6.1% after rise in 2016 guidance

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
Выбор редакции
24 августа 2016, 15:56

Quick Guide to Oppenheimer International Small-Mid Company Y Fund (OSMYX)

Oppenheimer International Small-Mid Company Y Fund (OSMYX) a Zacks Rank #2 (Buy) was incepted in November 1997 and is managed by Oppenheimer Funds Group